Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Apollo Device for Fatigue in Metastatic Breast Cancer

NCT04983342 is registered in ClinicalTrials.gov with Margaret Quinn Rosenzweig as lead sponsor.

NCT NCT04983342
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04983342 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Apollo Device for Fatigue in Metastatic Breast Cancer
Lead sponsor
Margaret Quinn Rosenzweig
Phase
Not applicable
Overall status
Completed
Start date
February 1, 2021
Completion date
August 9, 2022
Enrollment
27 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fatigue, metastatic breast carcinoma